KR100611796B1 - Cosmetic composition containing medicinal herbs called sipgeondaebodan and method for preparing the same - Google Patents
Cosmetic composition containing medicinal herbs called sipgeondaebodan and method for preparing the same Download PDFInfo
- Publication number
- KR100611796B1 KR100611796B1 KR1020050007989A KR20050007989A KR100611796B1 KR 100611796 B1 KR100611796 B1 KR 100611796B1 KR 1020050007989 A KR1020050007989 A KR 1020050007989A KR 20050007989 A KR20050007989 A KR 20050007989A KR 100611796 B1 KR100611796 B1 KR 100611796B1
- Authority
- KR
- South Korea
- Prior art keywords
- cosmetic composition
- weight
- extract
- ginseng
- skin
- Prior art date
Links
- 239000000203 mixture Substances 0.000 title claims abstract description 35
- 239000002537 cosmetic Substances 0.000 title claims abstract description 25
- 238000000034 method Methods 0.000 title description 12
- 235000008216 herbs Nutrition 0.000 title 1
- 241000208340 Araliaceae Species 0.000 claims abstract description 13
- 235000005035 Panax pseudoginseng ssp. pseudoginseng Nutrition 0.000 claims abstract description 13
- 235000003140 Panax quinquefolius Nutrition 0.000 claims abstract description 13
- 235000008434 ginseng Nutrition 0.000 claims abstract description 13
- 241001061264 Astragalus Species 0.000 claims abstract description 11
- 241000287828 Gallus gallus Species 0.000 claims abstract description 11
- 235000001453 Glycyrrhiza echinata Nutrition 0.000 claims abstract description 11
- 235000006200 Glycyrrhiza glabra Nutrition 0.000 claims abstract description 11
- 235000017382 Glycyrrhiza lepidota Nutrition 0.000 claims abstract description 11
- 235000006533 astragalus Nutrition 0.000 claims abstract description 11
- 229940010454 licorice Drugs 0.000 claims abstract description 11
- 210000004233 talus Anatomy 0.000 claims abstract description 11
- 244000170916 Paeonia officinalis Species 0.000 claims abstract description 9
- 235000006484 Paeonia officinalis Nutrition 0.000 claims abstract description 9
- 238000004519 manufacturing process Methods 0.000 claims abstract description 7
- 244000303040 Glycyrrhiza glabra Species 0.000 claims abstract description 4
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 claims description 12
- 239000000706 filtrate Substances 0.000 claims description 12
- 239000006071 cream Substances 0.000 claims description 10
- PUPZLCDOIYMWBV-UHFFFAOYSA-N (+/-)-1,3-Butanediol Chemical compound CC(O)CCO PUPZLCDOIYMWBV-UHFFFAOYSA-N 0.000 claims description 7
- 241000202807 Glycyrrhiza Species 0.000 claims description 7
- 239000006210 lotion Substances 0.000 claims description 6
- 235000015097 nutrients Nutrition 0.000 claims description 6
- 238000009472 formulation Methods 0.000 claims description 5
- 239000007864 aqueous solution Substances 0.000 claims description 4
- 239000000839 emulsion Substances 0.000 claims description 4
- 235000016709 nutrition Nutrition 0.000 claims description 4
- 230000035764 nutrition Effects 0.000 claims description 4
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 claims 1
- 229910052717 sulfur Inorganic materials 0.000 claims 1
- 239000011593 sulfur Substances 0.000 claims 1
- 235000001508 sulfur Nutrition 0.000 claims 1
- 102000008186 Collagen Human genes 0.000 abstract description 11
- 108010035532 Collagen Proteins 0.000 abstract description 11
- 229920001436 collagen Polymers 0.000 abstract description 11
- 230000003078 antioxidant effect Effects 0.000 abstract description 9
- 239000003963 antioxidant agent Substances 0.000 abstract description 7
- 230000015572 biosynthetic process Effects 0.000 abstract description 7
- 240000002045 Guettarda speciosa Species 0.000 abstract description 6
- 235000001287 Guettarda speciosa Nutrition 0.000 abstract description 6
- 238000003786 synthesis reaction Methods 0.000 abstract description 6
- 230000003020 moisturizing effect Effects 0.000 abstract description 4
- 239000000284 extract Substances 0.000 description 30
- 239000004615 ingredient Substances 0.000 description 21
- 230000000694 effects Effects 0.000 description 20
- 239000000243 solution Substances 0.000 description 17
- 210000004027 cell Anatomy 0.000 description 10
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 9
- 230000009471 action Effects 0.000 description 9
- 150000005846 sugar alcohols Polymers 0.000 description 8
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 8
- 238000002835 absorbance Methods 0.000 description 7
- 229940094952 green tea extract Drugs 0.000 description 7
- 235000020688 green tea extract Nutrition 0.000 description 7
- 238000002360 preparation method Methods 0.000 description 7
- 239000003755 preservative agent Substances 0.000 description 7
- 230000002335 preservative effect Effects 0.000 description 7
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 6
- 235000006708 antioxidants Nutrition 0.000 description 6
- 210000004369 blood Anatomy 0.000 description 6
- 239000008280 blood Substances 0.000 description 6
- 230000032683 aging Effects 0.000 description 5
- 238000001914 filtration Methods 0.000 description 5
- 239000002609 medium Substances 0.000 description 5
- PGSADBUBUOPOJS-UHFFFAOYSA-N neutral red Chemical compound Cl.C1=C(C)C(N)=CC2=NC3=CC(N(C)C)=CC=C3N=C21 PGSADBUBUOPOJS-UHFFFAOYSA-N 0.000 description 5
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 4
- 239000000796 flavoring agent Substances 0.000 description 4
- 235000019634 flavors Nutrition 0.000 description 4
- OVBPIULPVIDEAO-LBPRGKRZSA-N folic acid Chemical compound C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-LBPRGKRZSA-N 0.000 description 4
- 235000013305 food Nutrition 0.000 description 4
- 229930182494 ginsenoside Natural products 0.000 description 4
- 241000411851 herbal medicine Species 0.000 description 4
- 230000000144 pharmacologic effect Effects 0.000 description 4
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 3
- 239000006144 Dulbecco’s modified Eagle's medium Substances 0.000 description 3
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- 230000017531 blood circulation Effects 0.000 description 3
- 210000004204 blood vessel Anatomy 0.000 description 3
- 238000006243 chemical reaction Methods 0.000 description 3
- 239000003814 drug Substances 0.000 description 3
- 238000000605 extraction Methods 0.000 description 3
- 210000002950 fibroblast Anatomy 0.000 description 3
- 238000011534 incubation Methods 0.000 description 3
- JPXMTWWFLBLUCD-UHFFFAOYSA-N nitro blue tetrazolium(2+) Chemical compound COC1=CC(C=2C=C(OC)C(=CC=2)[N+]=2N(N=C(N=2)C=2C=CC=CC=2)C=2C=CC(=CC=2)[N+]([O-])=O)=CC=C1[N+]1=NC(C=2C=CC=CC=2)=NN1C1=CC=C([N+]([O-])=O)C=C1 JPXMTWWFLBLUCD-UHFFFAOYSA-N 0.000 description 3
- 230000035882 stress Effects 0.000 description 3
- ALSTYHKOOCGGFT-KTKRTIGZSA-N (9Z)-octadecen-1-ol Chemical compound CCCCCCCC\C=C/CCCCCCCCO ALSTYHKOOCGGFT-KTKRTIGZSA-N 0.000 description 2
- KSEBMYQBYZTDHS-HWKANZROSA-M (E)-Ferulic acid Natural products COC1=CC(\C=C\C([O-])=O)=CC=C1O KSEBMYQBYZTDHS-HWKANZROSA-M 0.000 description 2
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 2
- ICWHTQRTTHCUHW-IPYPFGDCSA-N 2-[(3s,5r,6r)-6,10-dimethylspiro[4.5]dec-9-en-3-yl]propan-2-ol Chemical compound C[C@@H]1CCC=C(C)[C@]11C[C@@H](C(C)(C)O)CC1 ICWHTQRTTHCUHW-IPYPFGDCSA-N 0.000 description 2
- ICWHTQRTTHCUHW-UHFFFAOYSA-N Agarospirol Natural products CC1CCC=C(C)C11CC(C(C)(C)O)CC1 ICWHTQRTTHCUHW-UHFFFAOYSA-N 0.000 description 2
- 238000002965 ELISA Methods 0.000 description 2
- 241000196324 Embryophyta Species 0.000 description 2
- 102000004190 Enzymes Human genes 0.000 description 2
- 108090000790 Enzymes Proteins 0.000 description 2
- WSFSSNUMVMOOMR-UHFFFAOYSA-N Formaldehyde Chemical compound O=C WSFSSNUMVMOOMR-UHFFFAOYSA-N 0.000 description 2
- 239000004378 Glycyrrhizin Substances 0.000 description 2
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 2
- QUBOHMMDFOUVHV-UHFFFAOYSA-N N(CCO)(CCO)CCO.OCC(O)CO.C(CC(C)O)O Chemical compound N(CCO)(CCO)CCO.OCC(O)CO.C(CC(C)O)O QUBOHMMDFOUVHV-UHFFFAOYSA-N 0.000 description 2
- OVBPIULPVIDEAO-UHFFFAOYSA-N N-Pteroyl-L-glutaminsaeure Natural products C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)NC(CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-UHFFFAOYSA-N 0.000 description 2
- YKRGDOXKVOZESV-WRJNSLSBSA-N Paeoniflorin Chemical compound C([C@]12[C@H]3O[C@]4(O)C[C@](O3)([C@]1(C[C@@H]42)O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)C)OC(=O)C1=CC=CC=C1 YKRGDOXKVOZESV-WRJNSLSBSA-N 0.000 description 2
- 235000002789 Panax ginseng Nutrition 0.000 description 2
- 229920001213 Polysorbate 20 Polymers 0.000 description 2
- 229920001214 Polysorbate 60 Polymers 0.000 description 2
- 206010039897 Sedation Diseases 0.000 description 2
- 229920002125 Sokalan® Polymers 0.000 description 2
- 229930006000 Sucrose Natural products 0.000 description 2
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 2
- 208000025865 Ulcer Diseases 0.000 description 2
- OIRDTQYFTABQOQ-KQYNXXCUSA-N adenosine Chemical compound C1=NC=2C(N)=NC=NC=2N1[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O OIRDTQYFTABQOQ-KQYNXXCUSA-N 0.000 description 2
- 230000000202 analgesic effect Effects 0.000 description 2
- UTMTYYKGLQURCK-UHFFFAOYSA-N butane-1,3-diol;propane-1,2,3-triol Chemical compound CC(O)CCO.OCC(O)CO UTMTYYKGLQURCK-UHFFFAOYSA-N 0.000 description 2
- 210000003169 central nervous system Anatomy 0.000 description 2
- 230000036570 collagen biosynthesis Effects 0.000 description 2
- 230000002708 enhancing effect Effects 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- KSEBMYQBYZTDHS-HWKANZROSA-N ferulic acid Chemical compound COC1=CC(\C=C\C(O)=O)=CC=C1O KSEBMYQBYZTDHS-HWKANZROSA-N 0.000 description 2
- 229940114124 ferulic acid Drugs 0.000 description 2
- KSEBMYQBYZTDHS-UHFFFAOYSA-N ferulic acid Natural products COC1=CC(C=CC(O)=O)=CC=C1O KSEBMYQBYZTDHS-UHFFFAOYSA-N 0.000 description 2
- 235000001785 ferulic acid Nutrition 0.000 description 2
- 235000019152 folic acid Nutrition 0.000 description 2
- 239000011724 folic acid Substances 0.000 description 2
- 229960000304 folic acid Drugs 0.000 description 2
- 230000006870 function Effects 0.000 description 2
- LPLVUJXQOOQHMX-UHFFFAOYSA-N glycyrrhetinic acid glycoside Natural products C1CC(C2C(C3(CCC4(C)CCC(C)(CC4C3=CC2=O)C(O)=O)C)(C)CC2)(C)C2C(C)(C)C1OC1OC(C(O)=O)C(O)C(O)C1OC1OC(C(O)=O)C(O)C(O)C1O LPLVUJXQOOQHMX-UHFFFAOYSA-N 0.000 description 2
- 229960004949 glycyrrhizic acid Drugs 0.000 description 2
- UYRUBYNTXSDKQT-UHFFFAOYSA-N glycyrrhizic acid Natural products CC1(C)C(CCC2(C)C1CCC3(C)C2C(=O)C=C4C5CC(C)(CCC5(C)CCC34C)C(=O)O)OC6OC(C(O)C(O)C6OC7OC(O)C(O)C(O)C7C(=O)O)C(=O)O UYRUBYNTXSDKQT-UHFFFAOYSA-N 0.000 description 2
- 235000019410 glycyrrhizin Nutrition 0.000 description 2
- LPLVUJXQOOQHMX-QWBHMCJMSA-N glycyrrhizinic acid Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@@H]1C([C@H]2[C@]([C@@H]3[C@@]([C@@]4(CC[C@@]5(C)CC[C@@](C)(C[C@H]5C4=CC3=O)C(O)=O)C)(C)CC2)(C)CC1)(C)C)C(O)=O)[C@@H]1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O LPLVUJXQOOQHMX-QWBHMCJMSA-N 0.000 description 2
- 230000011132 hemopoiesis Effects 0.000 description 2
- FDGQSTZJBFJUBT-UHFFFAOYSA-N hypoxanthine Chemical compound O=C1NC=NC2=C1NC=N2 FDGQSTZJBFJUBT-UHFFFAOYSA-N 0.000 description 2
- 230000006872 improvement Effects 0.000 description 2
- 230000005764 inhibitory process Effects 0.000 description 2
- 230000003834 intracellular effect Effects 0.000 description 2
- 229940057995 liquid paraffin Drugs 0.000 description 2
- LXCFILQKKLGQFO-UHFFFAOYSA-N methylparaben Chemical compound COC(=O)C1=CC=C(O)C=C1 LXCFILQKKLGQFO-UHFFFAOYSA-N 0.000 description 2
- 238000002156 mixing Methods 0.000 description 2
- 229940055577 oleyl alcohol Drugs 0.000 description 2
- XMLQWXUVTXCDDL-UHFFFAOYSA-N oleyl alcohol Natural products CCCCCCC=CCCCCCCCCCCO XMLQWXUVTXCDDL-UHFFFAOYSA-N 0.000 description 2
- YKRGDOXKVOZESV-UHFFFAOYSA-N paeoniflorin Natural products O1C(C)(C2(CC34)OC5C(C(O)C(O)C(CO)O5)O)CC3(O)OC1C24COC(=O)C1=CC=CC=C1 YKRGDOXKVOZESV-UHFFFAOYSA-N 0.000 description 2
- 239000008363 phosphate buffer Substances 0.000 description 2
- 239000000256 polyoxyethylene sorbitan monolaurate Substances 0.000 description 2
- 235000010486 polyoxyethylene sorbitan monolaurate Nutrition 0.000 description 2
- 239000001818 polyoxyethylene sorbitan monostearate Substances 0.000 description 2
- 235000010989 polyoxyethylene sorbitan monostearate Nutrition 0.000 description 2
- 229940068977 polysorbate 20 Drugs 0.000 description 2
- 229940113124 polysorbate 60 Drugs 0.000 description 2
- 230000002265 prevention Effects 0.000 description 2
- 230000028327 secretion Effects 0.000 description 2
- 230000036280 sedation Effects 0.000 description 2
- 230000005808 skin problem Effects 0.000 description 2
- 230000036548 skin texture Effects 0.000 description 2
- PRAKJMSDJKAYCZ-UHFFFAOYSA-N squalane Chemical compound CC(C)CCCC(C)CCCC(C)CCCCC(C)CCCC(C)CCCC(C)C PRAKJMSDJKAYCZ-UHFFFAOYSA-N 0.000 description 2
- 230000000638 stimulation Effects 0.000 description 2
- 238000003756 stirring Methods 0.000 description 2
- 239000011550 stock solution Substances 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 239000000758 substrate Substances 0.000 description 2
- 239000005720 sucrose Substances 0.000 description 2
- 235000000346 sugar Nutrition 0.000 description 2
- 210000001519 tissue Anatomy 0.000 description 2
- QURCVMIEKCOAJU-UHFFFAOYSA-N trans-isoferulic acid Natural products COC1=CC=C(C=CC(O)=O)C=C1O QURCVMIEKCOAJU-UHFFFAOYSA-N 0.000 description 2
- 210000004291 uterus Anatomy 0.000 description 2
- 229940099259 vaseline Drugs 0.000 description 2
- CUNWUEBNSZSNRX-RKGWDQTMSA-N (2r,3r,4r,5s)-hexane-1,2,3,4,5,6-hexol;(z)-octadec-9-enoic acid Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO.OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO.CCCCCCCC\C=C/CCCCCCCC(O)=O.CCCCCCCC\C=C/CCCCCCCC(O)=O.CCCCCCCC\C=C/CCCCCCCC(O)=O CUNWUEBNSZSNRX-RKGWDQTMSA-N 0.000 description 1
- 229940058015 1,3-butylene glycol Drugs 0.000 description 1
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 description 1
- QCDWFXQBSFUVSP-UHFFFAOYSA-N 2-phenoxyethanol Chemical compound OCCOC1=CC=CC=C1 QCDWFXQBSFUVSP-UHFFFAOYSA-N 0.000 description 1
- 206010000087 Abdominal pain upper Diseases 0.000 description 1
- NIXOWILDQLNWCW-UHFFFAOYSA-N Acrylic acid Chemical compound OC(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-N 0.000 description 1
- 206010001497 Agitation Diseases 0.000 description 1
- 101100042610 Arabidopsis thaliana SIGB gene Proteins 0.000 description 1
- 102000004506 Blood Proteins Human genes 0.000 description 1
- 108010017384 Blood Proteins Proteins 0.000 description 1
- 239000002126 C01EB10 - Adenosine Substances 0.000 description 1
- 206010053567 Coagulopathies Diseases 0.000 description 1
- 206010010904 Convulsion Diseases 0.000 description 1
- ZAKOWWREFLAJOT-CEFNRUSXSA-N D-alpha-tocopherylacetate Chemical compound CC(=O)OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C ZAKOWWREFLAJOT-CEFNRUSXSA-N 0.000 description 1
- 206010012442 Dermatitis contact Diseases 0.000 description 1
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 1
- 241000283074 Equus asinus Species 0.000 description 1
- 229920001503 Glucan Polymers 0.000 description 1
- UGQMRVRMYYASKQ-UHFFFAOYSA-N Hypoxanthine nucleoside Natural products OC1C(O)C(CO)OC1N1C(NC=NC2=O)=C2N=C1 UGQMRVRMYYASKQ-UHFFFAOYSA-N 0.000 description 1
- 235000018330 Macadamia integrifolia Nutrition 0.000 description 1
- 240000000912 Macadamia tetraphylla Species 0.000 description 1
- 235000003800 Macadamia tetraphylla Nutrition 0.000 description 1
- 208000004880 Polyuria Diseases 0.000 description 1
- 239000004372 Polyvinyl alcohol Substances 0.000 description 1
- 101100294408 Saccharomyces cerevisiae (strain ATCC 204508 / S288c) MOT2 gene Proteins 0.000 description 1
- YIQKLZYTHXTDDT-UHFFFAOYSA-H Sirius red F3B Chemical compound C1=CC(=CC=C1N=NC2=CC(=C(C=C2)N=NC3=C(C=C4C=C(C=CC4=C3[O-])NC(=O)NC5=CC6=CC(=C(C(=C6C=C5)[O-])N=NC7=C(C=C(C=C7)N=NC8=CC=C(C=C8)S(=O)(=O)[O-])S(=O)(=O)[O-])S(=O)(=O)O)S(=O)(=O)O)S(=O)(=O)[O-])S(=O)(=O)[O-].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+] YIQKLZYTHXTDDT-UHFFFAOYSA-H 0.000 description 1
- 208000005392 Spasm Diseases 0.000 description 1
- 208000007107 Stomach Ulcer Diseases 0.000 description 1
- 244000269722 Thea sinensis Species 0.000 description 1
- 235000006468 Thea sinensis Nutrition 0.000 description 1
- 208000007536 Thrombosis Diseases 0.000 description 1
- 239000013504 Triton X-100 Substances 0.000 description 1
- 229920004890 Triton X-100 Polymers 0.000 description 1
- FPIPGXGPPPQFEQ-BOOMUCAASA-N Vitamin A Natural products OC/C=C(/C)\C=C\C=C(\C)/C=C/C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-BOOMUCAASA-N 0.000 description 1
- 229930003779 Vitamin B12 Natural products 0.000 description 1
- 229930003427 Vitamin E Natural products 0.000 description 1
- 206010047631 Vitamin E deficiency Diseases 0.000 description 1
- 108010093894 Xanthine oxidase Proteins 0.000 description 1
- 102100033220 Xanthine oxidase Human genes 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 239000000980 acid dye Substances 0.000 description 1
- 230000003213 activating effect Effects 0.000 description 1
- 229960005305 adenosine Drugs 0.000 description 1
- 210000004404 adrenal cortex Anatomy 0.000 description 1
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 description 1
- IPZIYGAXCZTOMH-UHFFFAOYSA-N alpha-eudesmol Natural products CC1=CCCC2CCC(CC12)C(C)(C)O IPZIYGAXCZTOMH-UHFFFAOYSA-N 0.000 description 1
- 229940024606 amino acid Drugs 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 125000000129 anionic group Chemical group 0.000 description 1
- 230000003266 anti-allergic effect Effects 0.000 description 1
- 230000001093 anti-cancer Effects 0.000 description 1
- 230000002929 anti-fatigue Effects 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- 230000003064 anti-oxidating effect Effects 0.000 description 1
- 238000003556 assay Methods 0.000 description 1
- 235000013871 bee wax Nutrition 0.000 description 1
- 239000012166 beeswax Substances 0.000 description 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
- 238000001574 biopsy Methods 0.000 description 1
- 210000001124 body fluid Anatomy 0.000 description 1
- 239000010839 body fluid Substances 0.000 description 1
- 210000001185 bone marrow Anatomy 0.000 description 1
- 210000004958 brain cell Anatomy 0.000 description 1
- 239000000872 buffer Substances 0.000 description 1
- 235000019437 butane-1,3-diol Nutrition 0.000 description 1
- 229960001631 carbomer Drugs 0.000 description 1
- 238000004113 cell culture Methods 0.000 description 1
- 210000000170 cell membrane Anatomy 0.000 description 1
- 239000006285 cell suspension Substances 0.000 description 1
- OEYIOHPDSNJKLS-UHFFFAOYSA-N choline Chemical compound C[N+](C)(C)CCO OEYIOHPDSNJKLS-UHFFFAOYSA-N 0.000 description 1
- 229960001231 choline Drugs 0.000 description 1
- 125000002871 cinnamic aldehydes group Chemical group 0.000 description 1
- 230000035602 clotting Effects 0.000 description 1
- FDJOLVPMNUYSCM-WZHZPDAFSA-L cobalt(3+);[(2r,3s,4r,5s)-5-(5,6-dimethylbenzimidazol-1-yl)-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl] [(2r)-1-[3-[(1r,2r,3r,4z,7s,9z,12s,13s,14z,17s,18s,19r)-2,13,18-tris(2-amino-2-oxoethyl)-7,12,17-tris(3-amino-3-oxopropyl)-3,5,8,8,13,15,18,19-octamethyl-2 Chemical compound [Co+3].N#[C-].N([C@@H]([C@]1(C)[N-]\C([C@H]([C@@]1(CC(N)=O)C)CCC(N)=O)=C(\C)/C1=N/C([C@H]([C@@]1(CC(N)=O)C)CCC(N)=O)=C\C1=N\C([C@H](C1(C)C)CCC(N)=O)=C/1C)[C@@H]2CC(N)=O)=C\1[C@]2(C)CCC(=O)NC[C@@H](C)OP([O-])(=O)O[C@H]1[C@@H](O)[C@@H](N2C3=CC(C)=C(C)C=C3N=C2)O[C@@H]1CO FDJOLVPMNUYSCM-WZHZPDAFSA-L 0.000 description 1
- 238000004040 coloring Methods 0.000 description 1
- 230000000052 comparative effect Effects 0.000 description 1
- 208000010247 contact dermatitis Diseases 0.000 description 1
- 230000008602 contraction Effects 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 230000036461 convulsion Effects 0.000 description 1
- 210000004748 cultured cell Anatomy 0.000 description 1
- ZAKOWWREFLAJOT-UHFFFAOYSA-N d-alpha-Tocopheryl acetate Natural products CC(=O)OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C ZAKOWWREFLAJOT-UHFFFAOYSA-N 0.000 description 1
- 238000004042 decolorization Methods 0.000 description 1
- 230000007123 defense Effects 0.000 description 1
- 238000004332 deodorization Methods 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 230000029087 digestion Effects 0.000 description 1
- 230000001079 digestive effect Effects 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 208000035475 disorder Diseases 0.000 description 1
- 239000012153 distilled water Substances 0.000 description 1
- 230000035619 diuresis Effects 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 239000000975 dye Substances 0.000 description 1
- 210000000804 eccrine gland Anatomy 0.000 description 1
- 238000003912 environmental pollution Methods 0.000 description 1
- 230000010437 erythropoiesis Effects 0.000 description 1
- 230000002964 excitative effect Effects 0.000 description 1
- 230000029142 excretion Effects 0.000 description 1
- 210000003722 extracellular fluid Anatomy 0.000 description 1
- 239000000835 fiber Substances 0.000 description 1
- 235000011389 fruit/vegetable juice Nutrition 0.000 description 1
- WWULHQLTPGKDAM-UHFFFAOYSA-N gamma-eudesmol Natural products CC(C)C1CC(O)C2(C)CCCC(=C2C1)C WWULHQLTPGKDAM-UHFFFAOYSA-N 0.000 description 1
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 description 1
- FOYKKGHVWRFIBD-UHFFFAOYSA-N gamma-tocopherol acetate Natural products CC(=O)OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1 FOYKKGHVWRFIBD-UHFFFAOYSA-N 0.000 description 1
- 230000027119 gastric acid secretion Effects 0.000 description 1
- 230000002496 gastric effect Effects 0.000 description 1
- 201000005917 gastric ulcer Diseases 0.000 description 1
- 210000004907 gland Anatomy 0.000 description 1
- 150000004676 glycans Chemical class 0.000 description 1
- 230000003394 haemopoietic effect Effects 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 238000005534 hematocrit Methods 0.000 description 1
- 230000002218 hypoglycaemic effect Effects 0.000 description 1
- 230000036039 immunity Effects 0.000 description 1
- 230000016784 immunoglobulin production Effects 0.000 description 1
- 230000006054 immunological memory Effects 0.000 description 1
- 210000000936 intestine Anatomy 0.000 description 1
- 229910052742 iron Inorganic materials 0.000 description 1
- 230000007794 irritation Effects 0.000 description 1
- 230000003907 kidney function Effects 0.000 description 1
- 239000004816 latex Substances 0.000 description 1
- 229920000126 latex Polymers 0.000 description 1
- 230000000670 limiting effect Effects 0.000 description 1
- 210000003712 lysosome Anatomy 0.000 description 1
- 230000001868 lysosomic effect Effects 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 230000007721 medicinal effect Effects 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 239000004292 methyl p-hydroxybenzoate Substances 0.000 description 1
- 235000010270 methyl p-hydroxybenzoate Nutrition 0.000 description 1
- 229960002216 methylparaben Drugs 0.000 description 1
- 239000008267 milk Substances 0.000 description 1
- 235000013336 milk Nutrition 0.000 description 1
- 210000004080 milk Anatomy 0.000 description 1
- JXTPJDDICSTXJX-UHFFFAOYSA-N n-Triacontane Natural products CCCCCCCCCCCCCCCCCCCCCCCCCCCCCC JXTPJDDICSTXJX-UHFFFAOYSA-N 0.000 description 1
- 210000005036 nerve Anatomy 0.000 description 1
- 239000010466 nut oil Substances 0.000 description 1
- 239000003921 oil Substances 0.000 description 1
- 235000019198 oils Nutrition 0.000 description 1
- 229940126701 oral medication Drugs 0.000 description 1
- 210000005259 peripheral blood Anatomy 0.000 description 1
- 239000011886 peripheral blood Substances 0.000 description 1
- 230000003836 peripheral circulation Effects 0.000 description 1
- 229960005323 phenoxyethanol Drugs 0.000 description 1
- 230000001766 physiological effect Effects 0.000 description 1
- OXNIZHLAWKMVMX-UHFFFAOYSA-N picric acid Chemical class OC1=C([N+]([O-])=O)C=C([N+]([O-])=O)C=C1[N+]([O-])=O OXNIZHLAWKMVMX-UHFFFAOYSA-N 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- 229920002689 polyvinyl acetate Polymers 0.000 description 1
- 239000011118 polyvinyl acetate Substances 0.000 description 1
- 229920002451 polyvinyl alcohol Polymers 0.000 description 1
- 229920000036 polyvinylpyrrolidone Polymers 0.000 description 1
- 239000001267 polyvinylpyrrolidone Substances 0.000 description 1
- 235000013855 polyvinylpyrrolidone Nutrition 0.000 description 1
- 239000011148 porous material Substances 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 238000001243 protein synthesis Methods 0.000 description 1
- 239000001397 quillaja saponaria molina bark Substances 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 230000011514 reflex Effects 0.000 description 1
- 238000010992 reflux Methods 0.000 description 1
- 230000004648 relaxation of smooth muscle Effects 0.000 description 1
- 230000001850 reproductive effect Effects 0.000 description 1
- 239000009536 samultang Substances 0.000 description 1
- 229930182490 saponin Natural products 0.000 description 1
- 150000007949 saponins Chemical class 0.000 description 1
- 239000000932 sedative agent Substances 0.000 description 1
- 230000001624 sedative effect Effects 0.000 description 1
- 101150117326 sigA gene Proteins 0.000 description 1
- 230000009759 skin aging Effects 0.000 description 1
- 229960005078 sorbitan sesquioleate Drugs 0.000 description 1
- 229940032094 squalane Drugs 0.000 description 1
- 239000003270 steroid hormone Substances 0.000 description 1
- 230000004936 stimulating effect Effects 0.000 description 1
- 238000005728 strengthening Methods 0.000 description 1
- 150000008163 sugars Chemical class 0.000 description 1
- 125000001174 sulfone group Chemical group 0.000 description 1
- 230000009885 systemic effect Effects 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 210000001685 thyroid gland Anatomy 0.000 description 1
- 230000001256 tonic effect Effects 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- 230000014616 translation Effects 0.000 description 1
- 150000003626 triacylglycerols Chemical class 0.000 description 1
- 201000008827 tuberculosis Diseases 0.000 description 1
- 231100000397 ulcer Toxicity 0.000 description 1
- 230000002485 urinary effect Effects 0.000 description 1
- 239000002435 venom Substances 0.000 description 1
- 210000001048 venom Anatomy 0.000 description 1
- 231100000611 venom Toxicity 0.000 description 1
- 235000019155 vitamin A Nutrition 0.000 description 1
- 239000011719 vitamin A Substances 0.000 description 1
- 235000019163 vitamin B12 Nutrition 0.000 description 1
- 239000011715 vitamin B12 Substances 0.000 description 1
- 235000019165 vitamin E Nutrition 0.000 description 1
- 229940046009 vitamin E Drugs 0.000 description 1
- 239000011709 vitamin E Substances 0.000 description 1
- 229940045997 vitamin a Drugs 0.000 description 1
- 229920001285 xanthan gum Polymers 0.000 description 1
- 239000000230 xanthan gum Substances 0.000 description 1
- 235000010493 xanthan gum Nutrition 0.000 description 1
- 229940082509 xanthan gum Drugs 0.000 description 1
Classifications
-
- E—FIXED CONSTRUCTIONS
- E21—EARTH OR ROCK DRILLING; MINING
- E21B—EARTH OR ROCK DRILLING; OBTAINING OIL, GAS, WATER, SOLUBLE OR MELTABLE MATERIALS OR A SLURRY OF MINERALS FROM WELLS
- E21B49/00—Testing the nature of borehole walls; Formation testing; Methods or apparatus for obtaining samples of soil or well fluids, specially adapted to earth drilling or wells
- E21B49/08—Obtaining fluid samples or testing fluids, in boreholes or wells
- E21B49/084—Obtaining fluid samples or testing fluids, in boreholes or wells with means for conveying samples through pipe to surface
-
- E—FIXED CONSTRUCTIONS
- E21—EARTH OR ROCK DRILLING; MINING
- E21B—EARTH OR ROCK DRILLING; OBTAINING OIL, GAS, WATER, SOLUBLE OR MELTABLE MATERIALS OR A SLURRY OF MINERALS FROM WELLS
- E21B43/00—Methods or apparatus for obtaining oil, gas, water, soluble or meltable materials or a slurry of minerals from wells
- E21B43/02—Subsoil filtering
- E21B43/08—Screens or liners
-
- E—FIXED CONSTRUCTIONS
- E21—EARTH OR ROCK DRILLING; MINING
- E21B—EARTH OR ROCK DRILLING; OBTAINING OIL, GAS, WATER, SOLUBLE OR MELTABLE MATERIALS OR A SLURRY OF MINERALS FROM WELLS
- E21B49/00—Testing the nature of borehole walls; Formation testing; Methods or apparatus for obtaining samples of soil or well fluids, specially adapted to earth drilling or wells
- E21B49/08—Obtaining fluid samples or testing fluids, in boreholes or wells
- E21B49/081—Obtaining fluid samples or testing fluids, in boreholes or wells with down-hole means for trapping a fluid sample
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N1/00—Sampling; Preparing specimens for investigation
- G01N1/02—Devices for withdrawing samples
- G01N1/10—Devices for withdrawing samples in the liquid or fluent state
- G01N1/14—Suction devices, e.g. pumps; Ejector devices
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Geology (AREA)
- Engineering & Computer Science (AREA)
- Mining & Mineral Resources (AREA)
- Physics & Mathematics (AREA)
- Geochemistry & Mineralogy (AREA)
- Fluid Mechanics (AREA)
- General Life Sciences & Earth Sciences (AREA)
- Environmental & Geological Engineering (AREA)
- Analytical Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Hydrology & Water Resources (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- General Physics & Mathematics (AREA)
- Immunology (AREA)
- Pathology (AREA)
- Cosmetics (AREA)
Abstract
본 발명은 인삼, 백출, 복령, 당귀, 천궁, 숙지황, 작약, 황기, 육계 및 감초를 함유하는 화장료 조성물 및 이의 제조 방법을 제공한다. 본 발명에 따른 화장료 조성물은 피부 콜라겐 합성, 항산화 및 보습 효과가 있다. The present invention provides a cosmetic composition containing ginseng, Baekchul, Bokryeong, Angelica, Cheongung, Sukjihwang, Peony, Astragalus, Broiler, and Licorice, and a manufacturing method thereof. Cosmetic composition according to the invention has a skin collagen synthesis, antioxidant and moisturizing effect.
십전대보단(탕), 인삼, 백출, 복령, 당귀, 천궁, 숙지황, 작약, 황기, 육계, 감초, 화장료Beyond the Ten Thousand (Gang), Ginseng, Baekchul, Bokryeong, Dongguk, Cheongung, Sukjihwang, Peony, Astragalus, Broiler, Licorice, Cosmetics
Description
본 발명은 십전대보단 성분을 함유한 화장료 조성물 및 이의 제조 방법에 관한 것이다. The present invention relates to a cosmetic composition containing a component rather than a tenth generation and a method for producing the same.
일반적으로 십전대보단(탕)은 송(宋)나라 때의 방서(方書)인 『태평혜민화제국방(太平惠民和劑局方)』권 5에 처음 나오는 보약 중의 보약으로, 여러 가지 만성병이나 큰 병을 앓은 뒤 전신쇠약이 심하고, 기혈(氣血)·음양·표리(表裏)·내외(內外)가 모두 허해져 있을 때 남성의 기를 북돋운다고 하는 사군자탕과 여성의 피를 강화해준다고 하는 사물탕의 특성을 합하여 10가지 약재로 완성시킨 종합영양제격의 보약으로서, 체질과 남녀노소에 관계 없이 좋은 명약으로 알려져 있다. 현재는 경구투입용 보약으로서 이용되고 있다. In general, the tenth Jeonbodan (Tang) is a remedy among the first remedies in Volume 5 of the "Pacific Peace and Mindification Defense" book, written in the Song Dynasty. After a big illness, the systemic weakness and severe blood loss, yin and yang, the front and the back, both inside and outside, Sagunja-tang, which is said to encourage men's spirit, and Samul-tang, which is said to strengthen the blood of women, It is a remedy for a comprehensive nutrition that is completed with 10 kinds of medicinal properties, and is known as a good medicine regardless of constitution and age and sex. It is currently used as an oral medication.
상기한 십전대보단의 효능과 각 구성성분들의 약효를 하기에서 간략하게 살펴본다.The efficacy and efficacy of each component rather than the above-mentioned ten generations will be briefly described below.
상기 십전대보단은 중추신경의 기능을 활성화하여 대사능을 증진하므로써 비 특이적 면역능을 강화해주고, 골수를 자극하여 적혈구생성능을 강화하고 혈허(血虛)를 개선하여주고, 혈액순환을 촉진시켜주어 세포에 영양을 공급하여 도한을 완화하고 허약체질을 개선해주는 것으로 알려져 있다.The jeonseondae than by activating the function of the central nervous system to enhance the non-specific immunity by promoting metabolism, stimulating the bone marrow to strengthen the erythropoiesis, improve blood vessels (血虛), promote blood circulation It is known to nourish and relieve colds and improve weakness.
상기 십전대보단의 구성성분 중 하나인 인삼(人蔘)은 사포닌이 신경의 흥분전도를 가속화하고 조건반사능을 강화하여 피로를 경감시키고 작업능률을 높이며, 진세노사이드(ginsenosides) Rg1, Re, Rb2는 부신피질의 스테로이드 호르몬 분비능을 증진하여 면역기억세포의 생성을 촉진해주고, 아데노신, 진세노사이드 Rb1과 Re는 혈중의 중성지방(triglyceride)의 생성을 저하하고, 지노세사이드 Rg3와 Rg2는 혈소판 응고를 저해하여 혈전생성을 방지해주는 것으로 알려져 있다. 약리작용으로는 혈당강하작용, 항암효과, 혈청단백 합성촉진, 항체생산 촉진작용, 중추흥분작용, 항피로작용 등의 효능이 있는 것으로 알려져 있다.Ginseng (人蔘) is one of the components of the jeonseondae, saponin accelerates the excitatory conduction of nerves and strengthens the conditional reflexes to reduce fatigue and increase work efficiency, Ginsenosides (ginsenosides) Rg1, Re, Rb2 Promotes the production of immune memory cells by enhancing the steroid hormone secretion of the adrenal cortex, adenosine, ginsenosides Rb1 and Re decrease the production of triglycerides in the blood, and ginsenosides Rg3 and Rg2 stimulate platelet clotting Inhibition is known to prevent thrombus formation. Pharmacological action is known to have the effect of hypoglycemic action, anticancer effect, serum protein synthesis promotion, antibody production promotion action, central excitement action, anti-fatigue action.
백출(白朮)은 β-오데스몰(eudesmol)과 히네솔(hinesol)이 중추신경흥분을 억제하여 진정작용을 하며 소화액분비능을 항진하여 소화, 흡수를 촉진하고 위내강에 정체된 수독의 배출을 증진시켜주고, 약리작용으로는 비타민 A, D가 함유되어 자양작용을 하며, 모공을 수렴하여 지한작용을 하는 것으로 알려져 있다. Baekchul is a β-odesmol (eudesmol) and hinesol (Hinesol) to suppress the central nervous system stimulation sedation, promotes digestive juice secretion ability to promote digestion, absorption and promote the release of stagnant venom in the gastric lumen It is known that the pharmacological action is contained vitamin A, D to nourish, converging pores to act as a limiting action.
그리고, 복령(茯笭)은 포도당의 다당체인 파치만(pachyman)이 주성분으로 β-포도당이, 1→3결합을 한 글루칸(glucan)으로 모든 세포에 영양을 공급하고 뇌세포의 기능을 활성화하여 정신을 안정시키고 허약체질을 개선해주며, 약리작용은 위궤양 예방효과, 혈당강화 및 접촉성 피부염 억제작용 등이 있는 것으로 알려져 있다.In addition, the polysaccharide of pachyman, Pachyman, is a glucan with β-glucose as a main component and 1 → 3 binding. It supplies nutrition to all cells and activates brain cells. It stabilizes the mind and improves weakness, and the pharmacological action is known to have a gastric ulcer prevention effect, blood sugar strengthening and contact dermatitis inhibition.
당귀(當歸)는 비타민 B12, 폴산(folic acid), 철분이 있어서 조혈작용을 하여 혈허를 개선하고 혈액의 헤마토크릿(hematocrit)치를 높여주고, 비타민 E가 함유되어 있어 비타민 E 결핍증에 작용하며 자궁발육을 촉진해주며, 약리작용으로는 말초순환장애를 개선, 진정 및 진통작용, β-시토스테롤-O-글루사이드의 항염작용이 있다고 알려져 있다.Angelica has vitamin B12, folic acid, and iron to improve hematopoiesis by improving hematopoiesis, increase blood hematocrit level, and vitamin E, which acts on vitamin E deficiency and improves uterine development. Its pharmacological action is known to improve peripheral circulation disorder, sedative and analgesic action, and anti-inflammatory action of β-sitosterol-O-gluside.
천궁(川芎)은 페루라산(ferulic acid)이 진통, 진경작용과 평활근이완작용을 하여 장관의 경련이나 임신자궁의 수축, 경련을 억제한다.In the uterus, the ferulic acid (ferulic acid) is analgesic, pain relief and smooth muscle relaxation effect to suppress the spasm of the intestines, contraction of the pregnant uterus, convulsions.
현삼과에 속하는 지황(地黃)은 인체의 혈에 작용하여 보혈하고 비뇨 생식 기능을 도우는 작용을 가지고 있어서 머리를 검게 해주고 윤택하게 하는 작용이 있고, 건지황보다 숙지황이 조혈, 자윤작용이 강하다.Jihwang (地 黃) belonging to the Hyunsam family has the action to help the blood of the human body and urinary reproductive function to blacken and moisturize the hair, and heukjihwang is more hematopoietic, self-acting action than Guangjihwang.
작약(芍藥)은 패오니플로린(paeoniflorin)이 중추신경 흥분을 억제하여 진통, 진경, 진정작용을 하며 에크린(eccrine)선의 수렴능을 증가시켜 계지와 함께 지한(止汗)작용을 한다.Peony (芍藥) Paeoniflorin (paeoniflorin) suppresses the central nervous excitability, pain relief, jingyeong, sedation and increases the convergence ability of the eccrine gland (계) acts with the basin (止汗).
황기(黃耆)는 당류, 폴산, 콜린(Choline), 아미노산 등의 풍부한 영양분을 함유하고 있어 강장작용을 하며 세포에 영양을 공급하여 간질액의 피부외 배설을 억제하여 도한(盜汗)을 완화하고, 혈관을 확장하여 에크린(Eccrine)선의 자극을 완화하므로 체액의 과도한 체외배출을 억제하고 신장기능을 강화하여 이뇨를 증진한다.Astragalus contains abundant nutrients such as sugars, folic acid, choline, amino acids, etc., it is tonic and supplies nutrients to the cells to suppress the excretion of the interstitial fluid to reduce the cold. In addition, by dilatating the blood vessels to reduce the stimulation of the Ecrine (Eccrine) gland to suppress excessive extracorporeal discharge of body fluids and strengthen the kidney function to promote diuresis.
육계(肉桂)는 시나믹 알데히드(cinnamic aldehyde)가 혈관을 확장시켜 혈액순환을 촉진하고, 말초혈류를 촉진하여 피부말단의 한성(寒性) 농양, 괘양에 소산( 消散)작용과 수렴작용이 강하다.In broilers, cinnamic aldehydes expand blood vessels to promote blood circulation, promote peripheral blood flow, and have strong dissipation and astringent effects on cold abscesses and ulcers at the skin end. .
마지막으로 감초(甘草)는 글리시리진(glycyrrhizin)이 항알러지작용을 하고, 괘양수복 촉진작용과 위경련억제작용이 있으며 과도한 위산분비를 억제한다.Lastly, licorice (甘草) glycyrrhizin (glycyrrhizin) has an anti-allergic effect, ulcerative recovery and gastric spasms, and inhibits excessive gastric acid secretion.
그러나, 식품 또는 한약 성분으로 사용되는 식물 성분은 그것을 식품 또는 한약과 같이 경구 복용으로 투여하는 경우와 피부에 도포하는 경우와 같이 그 적용 방법이 상이하면 상이한 효과를 나타낼 수 있으며, 그 자체가 독성을 갖는 것이 많아 인체의 피부에 직접 도포시 피부 트러블을 일으키는 등의 문제를 발생시킬 수 있다. 따라서, 식품 또는 한약 성분으로 인체에 사용되던 것이라고 하더라도 이들을 피부에 적용하는 경우에는 피부에 문제를 일으키지 않도록 식물 성분의 종류와 투여량을 조절하는 것이 필요하다. 십전대보단의 경우도 한방에서 한약 성분으로서 전통적으로 사용되어져 경구 복용시 생체에 대한 안전성이 입증되고, 세포내 독성이 적은 생약 성분으로 알려져 있으나, 아직까지 이를 화장료 조성물에 사용된 예는 없다. However, plant components used as food or herbal ingredients may have different effects if they are applied differently, such as when administered orally, such as food or herbal medicines, and when applied to the skin, which itself is toxic. There are many things that can cause problems such as skin problems when applied directly to the skin of the human body. Therefore, even if it is used in the human body as a food or herbal ingredients, when applying them to the skin, it is necessary to adjust the type and dosage of plant components so as not to cause skin problems. In the case of the sub-Cheondaedae traditionally used as a herbal ingredient in herbal medicine has been proved to be safe for oral administration, and is known as a herbal ingredient with low intracellular toxicity, but it is not yet used in cosmetic compositions.
본 발명자들은 십전대보단의 성분들을, 종래의 용도와 같이 경구용으로 인체에 투여하지 않고, 피부에 직접 도포하는 경우 피부에 문제를 일으키지 않으면서 콜라겐 생합성, 항산화, 보습의 효과를 나타내고 피부를 진정시켜 피부결을 개선할 수 있다는 사실을 밝혀내었다. The present inventors do not administer to the human body by oral administration as in the conventional use, and when applied directly to the skin, it shows the effects of collagen biosynthesis, antioxidant, moisturizing and soothes the skin without causing problems to the skin. It has been found to improve skin texture.
이에 본 발명은 십전대보단 성분을 함유하는 화장료 조성물 및 이의 제조 방법을 제공하는 것을 목적으로 한다. Accordingly, an object of the present invention is to provide a cosmetic composition and a method for producing the same containing a component rather than a crossbone.
본 발명은 인삼, 백출, 복령, 당귀, 천궁, 숙지황, 작약, 황기, 육계 및 감초를 함유하는 화장료 조성물을 제공한다. The present invention provides a cosmetic composition containing ginseng, Baekchul, Bokryeong, Dongguk, Cheongung, Sukjihwang, Peony, Astragalus, Broiler and Licorice.
또한, 본 발명은 In addition, the present invention
i) 인삼, 백출, 복령, 당귀, 천궁, 숙지황, 작약, 황기, 육계 및 감초를 다가알콜 수용액과 혼합하고 숙성한 후 여과하여 그 여액을 얻는 단계, 및i) mixing ginseng, baekchul, bokyeong, donkey, cheongung, sukjihwang, peony, astragalus, broiler and licorice with a polyhydric alcohol solution, aging and filtering to obtain the filtrate, and
ii) 상기 여액을 함유하는 화장료 조성물을 제조하는 단계ii) preparing a cosmetic composition containing the filtrate
를 포함하는 화장료 조성물의 제조 방법을 제공한다. It provides a method for producing a cosmetic composition comprising a.
이하에서 본 발명을 구체적으로 설명한다. Hereinafter, the present invention will be described in detail.
본 발명자들은 십전대보단(탕)으로 알려져 있는 한약재 성분, 즉 인삼, 백출, 복령, 당귀, 천궁, 숙지황, 작약, 황기, 육계 및 감초를 인체의 피부에 도포하는 경우, 콜라겐 생합성, 항산화, 보습 및 피부결 개선의 효과를 얻을 수 있다는 점을 밝혀내어, 이들 성분을 포함하는 화장료 조성물을 발명하기에 이른 것이다. The inventors of the present invention, when applied to the skin of the Chinese herbal medicine ingredients known as jeonjeondaedan (tang), namely ginseng, baekrye, bokyeong, Angelica, Cheongung, Sukjiwang, Peony, Astragalus, broiler and licorice, collagen biosynthesis, antioxidant, moisturizing and It has been found that the effect of improving skin texture can be obtained, and it is therefore possible to invent a cosmetic composition containing these components.
본 발명에 있어서, 상기 성분들은 이들을 다가 알콜 수용액과 혼합하고, 숙성한 후, 여과하는 방법에 의하여 얻어진 여액의 형태로 화장료 조성물에 첨가될 수 있다. 이와 같은 추출방법은 종래 경구용으로 투여하기 위한 한약재의 추출 방식인 물에 담가 가열하는 방식과 상이한 방법이다. In the present invention, the components may be added to the cosmetic composition in the form of a filtrate obtained by mixing them with an aqueous polyhydric alcohol solution, aging and filtering. Such extraction method is different from the conventional method of immersing in water, which is an extraction method of herbal medicine for oral administration.
상기 추출방법에 있어서, 십전대보단 성분들과 다가 알콜 수용액의 첨가량은 각각 10-50중량% 및 50-90 중량%인 것이 바람직하다. 그리고, 본 발명에서 사용할 수 있는 다가 알콜 수용액은 20-50%의 다가 알콜인 것이 바람직하다. 상기 다가 알 콜로는 부틸렌글라이콜, 프로필렌글라이콜 등을 사용할 수 있으나, 이들에만 한정되는 것은 아니다. In the above extraction method, it is preferable that the addition amount of the components rather than the cross-substance and the polyhydric alcohol solution is 10-50% by weight and 50-90% by weight, respectively. And it is preferable that the aqueous polyhydric alcohol solution which can be used by this invention is 20-50% of polyhydric alcohol. The polyhydric alcohol may include butylene glycol, propylene glycol, and the like, but is not limited thereto.
또한, 상기 성분들과 다가 알콜 수용액의 혼합물을 숙성시키는 방법으로는 25-100℃ 물중탕에서 환류(reflux) 장치를 이용하는 방법이 있으나, 이에만 한정되는 것은 아니고 동일한 효과를 낼 수 있는 방법이라면 당기술분야에 알려져 있는 방법을 선택하여 사용할 수 있다. In addition, as a method of aging the mixture of the above components and a polyhydric alcohol solution, there is a method of using a reflux device in a water bath of 25-100 ℃, but not limited to this method if it can achieve the same effect Any method known in the art may be selected and used.
또한, 상기 여액을 얻는 방법에 있어서는 여과 후, 필요에 따라 탈색 및 탈취 과정을 더 수행할 수 있다. In addition, in the method of obtaining the filtrate, after filtration, it may be further carried out a decolorization and deodorization process.
본 발명에 있어서, 상기 십전대보단의 각 성분들은 피부 개선, 피부 보호 등 원하는 효과에 따라 함량비가 다를 수 있다. 본 발명에 따른 하나의 실시 상태에서는, 각 성분의 건조된 상태의 중량을 기준으로 인삼(人蔘) 1∼5중량%, 백출(白朮) 1∼5중량%, 복령(茯笭) 1∼5중량%, 당귀(當歸) 1∼5중량%, 천궁(川芎) 1∼5중량%, 숙지황(熟地黃) 1∼5중량%, 작약(芍藥) 1∼5중량%, 황기(黃耆) 1∼5중량%, 육계(肉桂) 1∼5중량% 및 감초(甘草) 1∼5중량%를 다가 알콜 수용액 50-90 중량%에 첨가하여 상기 성분들의 추출물을 제조할 수 있다. In the present invention, the content of each component of the cross-subsequence can be different depending on the desired effect, such as skin improvement, skin protection. In one embodiment according to the present invention, 1 to 5% by weight of ginseng, 1 to 5% by weight of white ginseng, 1 to 5 based on the dry weight of each component Weight%, Angelica 1-5%, Cheongung 1-5%, Sukjihwang 1-5%, Peony 1-5%, Astragalus 1 Extracts of the above ingredients can be prepared by adding -5% by weight, 1-5% by weight broiler, and 1-5% by weight licorice to 50-90% by weight aqueous polyhydric alcohol.
전술한 방법에 의하여 제조된 상기 십전대보단 성분들의 여액은 화장료 조성물 총 중량에 대하여 0.1∼15 중량%의 양으로 함유되어 있는 것이 바람직하다. 상기 여액이 0.1 중량% 미만이면 항산화 등의 효과가 미약하며, 15 중량%를 초과하는 경우에는 피부에 자극을 발생시킬 소지가 있다. It is preferable that the filtrate of the components rather than the cross-linked components prepared by the method described above is contained in an amount of 0.1 to 15% by weight based on the total weight of the cosmetic composition. If the filtrate is less than 0.1% by weight, the effect of antioxidant, etc. is weak, and if the filtrate exceeds 15% by weight may cause irritation to the skin.
본 발명에 따른 화장료 조성물은 그 제형에 의해 한정되지 않고, 당 기술분 야에 알려져 있는 제형을 취할 수 있다. 예컨대, 본 발명에 따른 화장료 조성물은 유연 화장수, 영양화장수, 영양유액, 유화상 크림(영양크림), 젤상 크림, 맛사지 크림, 엣센스 바디 오일, 메이크업 베이스, 화운데이션 및 팩 중에서 선택된 1종의 제형을 가질 수 있다. The cosmetic composition according to the present invention is not limited to the formulation, and may take a formulation known in the art. For example, the cosmetic composition according to the present invention may have one formulation selected from a flexible lotion, a nutrient lotion, a nutrient emulsion, an emulsion cream (nutrition cream), a gel cream, a massage cream, an essence body oil, a makeup base, a foundation, and a pack. Can be.
이하, 제조예, 실험예 및 처방예를 들어 본 발명을 보다 구체적으로 설명하지만, 이들은 본 발명을 예시하기 위한 것이며, 이들에 의하여 본 발명의 범위가 한정되는 것은 아니다. Hereinafter, the present invention will be described in more detail with reference to Preparation Examples, Experimental Examples, and Prescription Examples, but these are intended to illustrate the present invention, and the scope of the present invention is not limited thereto.
제조예 1 : 십전대보단 성분의 추출물 1의 제조Preparation Example 1: Preparation of extract 1 of the component
인삼 200g, 황기 200g, 복령 200g, 백출 200g, 당귀 200g, 백작약 200g, 천궁 200g, 육계 200g, 숙지황 200g 및 감초 200g을 45℃ 밀폐 용기에 넣고, 여기에 방부제로서 메칠파라벤 및 페녹시에탄올을 첨가한 후, 이를 30% 부틸렌글라이콜 수용액 5kg과 혼합하였다. 이 혼합물을 7일간 숙성한 후 여과하고, 이 여액에 활성탄을 첨가하여 6시간 교반 후 여과하는 공정을 2회 반복 후 4℃ 항온조에서 1일 침전시켜 여과하여 추출물 1을 얻었다. Ginseng 200g, Astragalus 200g, Bokryeong 200g, Baekchul 200g, Angelica 200g, Baekjak 200g, Cheonung 200g, Broiler 200g, 200g of sucrose and 200g licorice in a 45 ° C sealed container, to which methylparaben and phenoxyethanol were added as a preservative. This was then mixed with 5 kg of 30% butylene glycol aqueous solution. After aging for 7 days, the mixture was filtered and filtered. Activated carbon was added to the filtrate, followed by stirring for 6 hours, followed by filtration twice. The mixture was precipitated in a constant temperature bath at 4 ° C. for 1 day and filtered to obtain an extract 1.
제조예 2 : 십전대보단 성분의 추출물 2의 제조Preparation Example 2 Preparation of Extract 2 of the Component
인삼 200g, 황기 200g, 복령 200g, 백출 200g, 당귀 200g, 백작약 200g, 천궁 200g, 육계 200g, 숙지황 200g, 감초 200g을 적량의 방부제를 처리한 30% 부틸렌글라이콜 수용액 5kg과 혼합하였다. 이 혼합물을 100℃하에서 24시간 숙성한 후 여과하고, 이 여액에 활성탄을 첨가하여 6시간 교반 후 여과하는 공정을 2회 반복 후 4℃ 항온조에서 1일 침전시켜 여과하여 추출물 2를 얻었다. 200 g of ginseng, 200 g of Astragalus, 200 g of Fuling, 200 g of Baekchul, 200 g of Angelica ginseng, 200 g of Baekjak, 200 g of Cheongung, 200 g of broiler, 200 g of sucrose and 200 g of licorice were mixed with 5 kg of 30% butylene glycol aqueous solution treated with an appropriate amount of preservative. After aging for 24 hours at 100 ° C., the mixture was filtered. Activated carbon was added to the filtrate, followed by stirring for 6 hours, followed by filtration twice. The mixture was precipitated in a 4 ° C. thermostat for 1 day and filtered to obtain Extract 2.
상기 제조예 1 및 제조예 2에서 제조된 추출물을 이용하여 이하의 실시예에서 콜라겐 합성 효과 및 항산화 효과를 측정하였다. 비교 물질로는 홍삼 추출물 또는 녹차 추출물을 이용하였다. Collagen synthesis and antioxidant effects were measured in the following examples using extracts prepared in Preparation Examples 1 and 2. Red ginseng extract or green tea extract was used as a comparative substance.
실험예 1Experimental Example 1
콜라겐 합성(collagen synthesis) 효과 측정Determination of collagen synthesis effect
실험 원리Experiment principle
강 음이온성 산 염료인 피크로시리어스 염료(picrosirius dye) (상품명 : Sirius red F3B, BDH, UK)를 이용하여, 콜라겐 분자의 염기성 기와 시리어스 레드의 술폰기의 결합으로 콜라겐을 착색하는, 비교적 특이적이고 간단한 방법으로서, 최근 많이 사용되고 있다. 주로 조직의 생체검사나 파이버(fiber) 등의 콜라겐을 착색하는데 사용되어져 왔으나, 세포배양을 통하여 생성된 콜라겐량을 측정하는데 응용한 방법이다.A relatively specific, pigmented collagen by combining the basic group of the collagen molecule with the sulfone group of the serious red using picrosirius dye (trade name: Sirius red F3B, BDH, UK), which is a strong anionic acid dye. As a simple method, it has been used a lot recently. It has been used mainly for biopsy of tissues and for coloring collagen such as fibers, but it is a method applied to measuring the amount of collagen produced through cell culture.
실험 방법Experiment method
인간의 정상 섬유아세포(human normal fibroblast)를 96 웰 플레이트에 1 × 105/cell이 되도록 접종하고, 5% FBS가 함유된 DMEM·F'10(1 : 1) 배지로 분주하였다. 24시간 배양 후 새로운 5% FBS가 함유된 DMEM·F'10(1 : 1) 배지로 교환 후, 십전대보단 성분의 추출물을 하기 표 1의 농도로 처리하였다. 72시간 배양 후 웰 플레이트를 -20℃와 상온을 번갈아가면서 해빙(thawing)을 하여 세포를 분쇄하였다. 배지를 잘 혼합한 다음, 배지 150㎕에 0.1% 시리어스 레드 용액(포화 피크르산(picric acid) 100㎖에 시리어스 레드 F3B를 0.1g 녹인 용액)을 1㎖ 가하여 상온에 서 24시간 방치시켰다. Human normal fibroblasts were seeded in 96 well plates at 1 × 10 5 / cell and dispensed with DMEM · F′10 (1: 1) medium containing 5% FBS. After 24 hours of incubation, the cells were replaced with fresh 5% FBS-containing DMEM.F'10 (1: 1) medium, and then the extract of the subsidiary group was treated to the concentration of Table 1 below. After incubation for 72 hours, the well plate was thawed while alternating with -20 ° C and room temperature to grind the cells. After the medium was well mixed, 1 ml of 0.1% serious red solution (solution dissolved in 0.1 g of serious red F3B in 100 ml of saturated picric acid) was added to 150 µl of the medium, and the mixture was left at room temperature for 24 hours.
반응물을 10,000rpm, 5분간 원심분리한 후, 결합되지 않은 시리어스 레드 용액을 버리고, 0.01N HCl을 넣어 3회 세척한 후, 0.1N NaOH를 1㎖첨가하여 시리어스 레드와 결합된 콜라겐을 용해시켰다. 이를 ELISA 판독기를 이용하여 540 nm에서 흡광도를 측정하였다. 모든 시험 결과는 세포를 배양하지 않은 웰에서의 흡광도로 보정하였다.After the reaction was centrifuged at 10,000 rpm for 5 minutes, the unbound serious red solution was discarded, washed three times with 0.01 N HCl, and 1 ml of 0.1 N NaOH was added to dissolve the collagen bound with serious red. This was measured for absorbance at 540 nm using an ELISA reader. All test results were corrected for absorbance in wells in which the cells were not cultured.
상기 표 1로부터, 45℃에서 7일간 추출한 추출물 1 및 95℃에서 24시간 추출한 추출물 2 모두 0.5%의 농도로 사용할 때, 약 30%이상의 콜라겐 합성효과를 나타낸다는 것을 알 수 있다.From Table 1, it can be seen that the extract 1 extracted at 45 ° C for 7 days and the extract 2 extracted at 95 ° C for 24 hours when used at a concentration of 0.5%, the collagen synthesis effect of about 30% or more.
실험예 2Experimental Example 2
항산화(anti-oxidation)효과 측정Anti-oxidation effect measurement
DPPH(1,1-디페닐-2-피크릴-히드라질) 방법DPPH (1,1-diphenyl-2-picryl-hydrazyl) method
DPPH는 시그마(SIG1, 1190, 1958)MA)사의 것을 사용하였다. DPPH를 메탄올에 녹였다. 이 때 메탄올이 원액인 경우 증발될 가능성이 있으므로, 증류수와 6:4의 비율로 모액(stock solution)을 만들어 녹였다. 이렇게 녹인 DPPH 용액을 513nm에서 흡광도가 0.6 정도 되도록 맞추었다. DPPH 용액 2ml를 농도에 따라 희석한 추출 물 시료 1ml에 각각 첨가하여 혼합하였다. 상온에서 약 1시간 동안 방치한 후, 513nm에서 흡광도를 측정하였다.DPPH was used as Sigma (SIG1, 1190, 1958) MA). DPPH was dissolved in methanol. At this time, since methanol may be evaporated if it is a stock solution, a stock solution was prepared and dissolved in a ratio of 6: 4 with distilled water. The dissolved DPPH solution was adjusted to have an absorbance of about 0.6 at 513 nm. 2 ml of DPPH solution was added to and mixed with 1 ml of the diluted extract sample. After standing at room temperature for about 1 hour, the absorbance at 513 nm was measured.
상기 표 2로부터, 5%이상 십전대보단을 사용할 경우, 제조예 1과 2의 십전대보단 추출물이 녹차 추출물(Green Tea, 학명:camellia sinensis)과 유사한 항산화 효과를 나타낸다는 것을 알 수 있다.From the above Table 2, it can be seen that when using more than 5% of the jeonseondae, extracts of jeonseondae than Preparation Example 1 and 2 shows an antioxidant effect similar to the green tea extract (Green Tea, scientific name: camellia sinensis).
NBT assayNBT assay
300mM 포스페이트 버퍼(pH 7.8)에 트리톤(triton) X-100 1.6ml, EDTA 2.9mg, NBT(니트로블루-테트라졸륨, 시그마) 1mg, 하이포크산틴(hypoxanthine) 5.4mg을 넣어 기질/반응 용액을 만들었다. 크산틴 옥시다제 12㎕를 300mM 포스페이트 버퍼(pH 7.8) 10ml에 녹여 효소 용액을 만들었다. 분광 광도계 셀 내에 버퍼 1.0ml을 넣은 다음, 만들어 놓은 기질/반응 용액을 0.5ml 첨가하였다. 농도에 따라 희석한 하기 표 3의 시료를 각각 100㎕씩 처리하였다. 여기에 효소 용액 0.5ml을 첨가하고 37℃에서 30분간 반응시킨 후 540ml에서 흡광도를 측정한다.Substrate / reaction solution was prepared by adding 1.6 ml of Triton X-100, 2.9 mg of EDTA, 1 mg of NBT (nitroblue-tetrazolium, Sigma), and 5.4 mg of hypoxanthine in 300 mM phosphate buffer (pH 7.8). 12 μl of xanthine oxidase was dissolved in 10 ml of 300 mM phosphate buffer (pH 7.8) to make an enzyme solution. 1.0 ml of the buffer was placed in the spectrophotometer cell, and 0.5 ml of the prepared substrate / reaction solution was added. 100 μl of the samples in Table 3 diluted according to the concentration was treated. 0.5 ml of enzyme solution is added thereto and reacted at 37 ° C. for 30 minutes, and then absorbance is measured at 540 ml.
상기 표 3을 통하여, 십전대보단 성분 추출물 1 및 2는 모두 5%의 농도에서 녹차추출물과 유사한 항-수퍼옥사이드 음이온 활성 효과를 나타낸다는 것을 알 수 있다.Through the above Table 3, it can be seen that the extracts 1 and 2 than the sub-Taekdae both show an anti-superoxide anion activity effect similar to the green tea extract at a concentration of 5%.
DCFH-DA(마우스 섬유아세포 L929 이용)DCFH-DA (using mouse fibroblast L929)
트립신화(Trypsinization)에 의해 회수한 형질전환된 마우스 섬유아세포 L929를 5% BCS가 함유된 DMEM·F'10 배지로 현탁시킨 후, 96 웰 조직 배양 플레이트의 각각의 웰에 세포현탁액(5000-10000cells/well) 100㎕를 접종한 다음, 37℃에서 5% CO2 조건으로 24시간 배양하였다. 이어서, 각각의 웰에 하기 표 4에 기재된 시료 10㎕를 처리하고, 다시 15분, 30분, 45분, 60분 및 120분까지 시간별로 배양한 후, 각 웰에 100㎕의 뉴트럴 레드 솔루션(neutral red solution)(50㎍/ml)을 첨가하고 3시간동안 반응시켰다. Transformed mouse fibroblast L929 recovered by Trypsinization was suspended in DMEM.F'10 medium containing 5% BCS, and then cell suspension (5000-10000cells) in each well of a 96 well tissue culture plate. / well) 100 μl was inoculated and then incubated at 37 ° C. under 5% CO 2 conditions for 24 hours. Subsequently, each well was treated with 10 μl of the sample shown in Table 4, followed by further incubation for 15 minutes, 30 minutes, 45 minutes, 60 minutes and 120 minutes, followed by 100 μl of neutral red solution ( neutral red solution) (50 µg / ml) was added and reacted for 3 hours.
뉴트럴 레드가 완전히 원형질막을 통과하여 살아있는 세포 또는 손상받지 않은 세포의 리소좀(lysosome)에 농축된 후, 1.0% 포르말린/1.0% CaCl2 100㎕로 고정한 다음, 1.0% 아세트산/50% 에탄올 용액을 사용하여 세포 내의 뉴트럴 레드를 추출하였다. 추출된 뉴트럴 레드를 ELISA 판독기를 이용하여 540nm에서 흡광도를 측정하였다. 모든 실험결과는 세포를 배양하지 않은 웰에서 측정된 흡광도로 보정하 였다.Neutral Red is completely concentrated through the plasma membrane into the lysosomes of live or intact cells, fixed with 100 μl of 1.0% formalin / 1.0% CaCl 2 and then using 1.0% acetic acid / 50% ethanol solution. Neutral red in the cells was extracted. The extracted neutral red was measured for absorbance at 540 nm using an ELISA reader. All experimental results were corrected with absorbance measured in wells without cultured cells.
상기 표 4를 통하여, 95℃에서 24시간 추출한 추출물 2는 세포내 항산화 스트레스 활성에서도 녹차추출물과 유사한 효과를 나타냄을 알 수 있다.Through Table 4, it can be seen that the extract 2 extracted at 95 ℃ for 24 hours shows a similar effect to the green tea extract in the intracellular antioxidant stress activity.
이하에서는 본 발명에 따른 화장료 조성물의 제형에 따른 처방예를 설명한다. Hereinafter will be described a prescription example according to the formulation of the cosmetic composition according to the present invention.
[처방예 1][Prescription Example 1]
본 발명에 따른 십전대보단 성분을 함유하는 유연 화장수(스킨)는 다음과 같은 구성으로 처방될 수 있다. Flexible skin lotion (skin) containing a component rather than a crossbone according to the present invention can be prescribed in the following configuration.
[처방예 2][Prescription 2]
본 발명에 따른 십전대보단 성분을 함유하는 영양 유액(밀크로션)의 처방예는 다음과 같다.Prescription examples of nutrient latex (milk lotion) containing a component rather than the thyroid in accordance with the present invention is as follows.
[처방예 3][Prescription 3]
본 발명에 따른 십전대보단 성분을 함유하는 영양 크림의 처방예는 다음과 같다.A prescription example of a nourishing cream containing a component rather than a tenth generation according to the present invention is as follows.
[처방예 4][Prescription 4]
본 발명에 따른 십전대보단 성분을 함유하는 맛사지 크림의 처방예는 다음과 같다.A prescription example of a massage cream containing a component rather than a crossbone according to the present invention is as follows.
[처방예 5][Prescription 5]
본 발명에 따른 십전대보단 성분을 함유하는 팩의 처방예는 다음과 같다.Prescription example of a pack containing a component rather than a cross according to the present invention is as follows.
[처방예 6][Prescription 6]
본 발명에 따른 십전대보단 성분을 함유하는 엣센스의 처방예는 다음과 같다.A prescription example of an essence containing a component rather than a cross teen according to the present invention is as follows.
본 발명은 신체를 건강하게 하기 위한 보약으로서 식품이나 한약같이 경구 투여로만 사용되던 십전대보단의 성분을 피부 도포용 화장료 조성물에 첨가하여 사용함으로써, 피부 콜라겐 합성, 항산화 및 보습 효과를 제공하여, 연령, 스트레스, 자외선, 환경오염, 건조등으로 인해 저하된 피부의 생리활성을 강화시켜 피부 노화 방지 및 피부 보호, 피부 개선에 기여할 수 있다. The present invention provides a skin collagen synthesis, antioxidant and moisturizing effect by adding to the cosmetic composition for applying the skin to the cosmetic composition for skin application, which is used only by oral administration such as food or Chinese medicine as a medicine for health to the body, age, It can contribute to the prevention of skin aging, skin protection, and skin improvement by enhancing the physiological activity of the skin degraded by stress, ultraviolet rays, environmental pollution, and drying.
Claims (6)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020050007989A KR100611796B1 (en) | 2005-01-28 | 2005-01-28 | Cosmetic composition containing medicinal herbs called sipgeondaebodan and method for preparing the same |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020050007989A KR100611796B1 (en) | 2005-01-28 | 2005-01-28 | Cosmetic composition containing medicinal herbs called sipgeondaebodan and method for preparing the same |
Publications (2)
Publication Number | Publication Date |
---|---|
KR20060087134A KR20060087134A (en) | 2006-08-02 |
KR100611796B1 true KR100611796B1 (en) | 2006-08-10 |
Family
ID=37176108
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1020050007989A KR100611796B1 (en) | 2005-01-28 | 2005-01-28 | Cosmetic composition containing medicinal herbs called sipgeondaebodan and method for preparing the same |
Country Status (1)
Country | Link |
---|---|
KR (1) | KR100611796B1 (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR100864174B1 (en) | 2007-05-16 | 2008-10-22 | (주)코바스 | Cosmetic composition comprising an extract of mixed herbal tgt having skin whitening and anti-aging activity |
Families Citing this family (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP5398129B2 (en) * | 2007-07-02 | 2014-01-29 | 小林製薬株式会社 | Skin metabolism promoter |
KR101050754B1 (en) * | 2008-09-04 | 2011-07-21 | 주식회사심비오즈코스메틱스 | Cosmetic composition for skin protection comprising the complex herbal extract |
KR20110001407A (en) * | 2009-06-30 | 2011-01-06 | (주)아모레퍼시픽 | Composition containing rehmannia glutinosa, radix glycyrrhizae, semen coicis, fructus hordei, fructus chaenomelis, cortex acanthopanacis, or radix puerariae extract for promoting adipocyte differenciation |
KR101640735B1 (en) * | 2010-03-09 | 2016-07-29 | 주식회사 엘지생활건강 | Composition for improving skin wrinkle |
KR101640736B1 (en) * | 2010-03-09 | 2016-07-29 | 주식회사 엘지생활건강 | Composition for improving skin wrinkle |
CN115317588B (en) * | 2022-09-26 | 2024-04-05 | 东阿阿胶股份有限公司 | Preparation method of Baoyuan decoction, baoyuan extract and Baoyuan solid preparation |
CN117653577B (en) * | 2024-01-31 | 2024-05-07 | 惠州安博臣科技有限公司 | Composition for improving sub-health state of skin and preparation method thereof |
-
2005
- 2005-01-28 KR KR1020050007989A patent/KR100611796B1/en active IP Right Grant
Non-Patent Citations (1)
Title |
---|
인터넷자료 |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR100864174B1 (en) | 2007-05-16 | 2008-10-22 | (주)코바스 | Cosmetic composition comprising an extract of mixed herbal tgt having skin whitening and anti-aging activity |
Also Published As
Publication number | Publication date |
---|---|
KR20060087134A (en) | 2006-08-02 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
KR100611796B1 (en) | Cosmetic composition containing medicinal herbs called sipgeondaebodan and method for preparing the same | |
KR101898688B1 (en) | Composition for preventing, treating or improving muscle atrophy comprising complex extracts | |
CN102579972B (en) | Traditional Chinese medicine composition and preparation with effect of relieving dark eye circles and preparation method of traditional Chinese medicine composition and preparation | |
CN108391774A (en) | A kind of drinks of antigout and preparation method thereof | |
CN112190593B (en) | Polysaccharide composition for inhibiting TRPV1 pathway and preparation method and application thereof | |
CN106420531A (en) | Traditional Chinese medicine composite extract containing nepeta angustifolia and having skin whitening and moisturizing function and application | |
KR100633380B1 (en) | Compositions of oriental cosmetics for atopy skin containing mixture of specific herbal extracts | |
WO2019132625A1 (en) | Composition for preventing, improving or treating atopic dermatitis containing mixed herbal extract as active ingredient | |
CN102846499A (en) | Composition having effects of whitening, removing spots and refreshing skin | |
CN101433666B (en) | Anti-aging Chinese herbal medicinal composition, preparation method and use thereof | |
KR20130105003A (en) | Cosmetic composition for improving atopic skin comprising herb extract fermented in bamboo cylinder and manufacturing method thereof | |
JP2013203683A (en) | Type iii collagen production promotor | |
KR20130039145A (en) | Composition for preventing hair loss or promoting hair growth comprising extracts of panax ginseng and hijikia fusiforme | |
KR100800359B1 (en) | A composition having depilation preventing and trichogenousness effect | |
CN108813465A (en) | A kind of fig function chewable tablets and preparation method thereof | |
CN105770078B (en) | Pharmaceutical composition, preparation and application thereof | |
KR20070036224A (en) | Cosmetic compositions comprising crude drug complex | |
CN103432192A (en) | Composition with slimming function | |
CN105434738A (en) | Traditional Chinese medicine composition for treating ADHD (Attention Deficit Hyperactivity Disorder) and preparation method thereof | |
CN106214622A (en) | Moisturizing maintenance cosmetic water and preparation method thereof | |
CN107281084A (en) | A kind of whitening Chinese medicament mask and preparation method thereof | |
CN106928376A (en) | The separation method of skunk bush polysaccharide and its application | |
CN108813500B (en) | Health-preserving honey paste with effects of tonifying middle-jiao and Qi, nourishing blood and soothing nerves and regulating human body functions | |
CN112402569A (en) | Anti-fatigue health product and preparation method thereof | |
KR101121736B1 (en) | Medicinal herb extracts for skin whitening, a method of manufacturing the same and skin whitening cosmetics containing the same |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A201 | Request for examination | ||
E902 | Notification of reason for refusal | ||
E701 | Decision to grant or registration of patent right | ||
GRNT | Written decision to grant | ||
FPAY | Annual fee payment |
Payment date: 20130703 Year of fee payment: 8 |
|
FPAY | Annual fee payment |
Payment date: 20140704 Year of fee payment: 9 |
|
FPAY | Annual fee payment |
Payment date: 20150714 Year of fee payment: 10 |
|
FPAY | Annual fee payment |
Payment date: 20160715 Year of fee payment: 11 |
|
FPAY | Annual fee payment |
Payment date: 20170803 Year of fee payment: 12 |
|
FPAY | Annual fee payment |
Payment date: 20180803 Year of fee payment: 13 |
|
FPAY | Annual fee payment |
Payment date: 20190716 Year of fee payment: 14 |